banner
Chromogenic substrate 5-bromo-4-chloro-3-indolyl N-acetyl β-D-galactosaminide
Inquiry

Cat. No.: X24-02-LY006

Chromogenic substrate 5-bromo-4-chloro-3-indolyl N-acetyl β-D-galactosaminide

Synonym: 129572-48-1; 5-Bromo-4-chloro-3-indolyl 2-acetamido-2-deoxy-β-D-galactopyranoside; X-GalNAc; X-N-acetyl-beta-D-galactosaminide

  • CAS Number: 129572-48-1
  • Compound CID: 9955373
img
Product Size
100 mg; 250 mg; 500 mg; 1 g
Price
Datasheet
MSDS
Properties
Description
5-Bromo-4-chloro-3-indolyl N-acetyl β-D-galactosaminide is a potent chromogenic substrate for glycosidases and rapid hydrolysis of β-D-galactosides.
Molecular Weight
449.7
Molecular Formula
C16H18BrClN2O6
Form
Solid
Purity
>98%, determined by HPLC.
Solubility
It is soluble in dimethylformamide/water 1:1 v/v.
Identity
Confirmed by HPLC and NMR.
Applications
5-Bromo-4-chloro-3-indolyl N-acetyl β-D-galactosaminide is widely used in molecular biology such as identification of enzyme activity in cells and tissues.
Safety Information
Personal Protective Equipment
Gloves, Safety glasses, FFP2 or N95 masks
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0